SG
GILD icon

StoneX Group’s Gilead Sciences GILD Stock Holding History

StoneX Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$276K Sell
2,181
-337
-13% -$44.4K 0.01% 881
2026
Q1 		$351K Sell
2,518
-1,655
-40% -$232K 0.02% 518
2025
Q4 		$512K Sell
4,173
-127
-3% -$15.4K 0.02% 526
2025
Q3 		$477K Buy
4,300
+192
+5% +$21.8K 0.02% 558
2025
Q2 		$455K Sell
4,108
-1,568
-28% -$167K 0.02% 533
2025
Q1 		$636K Buy
5,676
+1,268
+29% +$131K 0.03% 409
2024
Q4 		$407K Sell
4,408
-2,134
-33% -$192K 0.02% 518
2024
Q3 		$549K Buy
6,542
+563
+9% +$43K 0.04% 339
2024
Q2 		$410K Sell
5,979
-696
-10% -$46.4K 0.03% 384
2024
Q1 		$489K Sell
6,675
-4,854
-42% -$373K 0.04% 320
2023
Q4 		$934K Sell
11,529
-5,406
-32% -$421K 0.09% 190
2023
Q3 		$1.27M Buy
16,935
+7,002
+70% +$539K 0.14% 134
2023
Q2 		$766K Sell
9,933
-735
-7% -$58.6K 0.08% 218
2023
Q1 		$885K Buy
10,668
+3,135
+42% +$260K 0.1% 192
2022
Q4 		$647K Sell
7,533
-23
-0.3% -$1.82K 0.08% 238
2022
Q3 		$466K Buy
7,556
+2,865
+61% +$181K 0.06% 281
2022
Q2 		$290K Sell
4,691
-46
-1% -$2.85K 0.04% 427
2022
Q1 		$282K Buy
4,737
+88
+2% +$5.63K 0.02% 488
2021
Q4 		$338K Buy
+4,649
New +$320K 0.04% 376
2021
Q3 		– Sell
-2,918
Closed -$201K – 483
2021
Q2 		$201K Buy
+2,918
New +$195K 0.03% 452
2018
Q4 		– Sell
-3,786
Closed -$292K – 216
2018
Q3 		$292K Buy
3,786
+146
+4% +$11K 0.22% 166
2018
Q2 		$258K Sell
3,640
-190
-5% -$13.4K 0.22% 179
2018
Q1 		$289K Buy
3,830
+103
+3% +$8.19K 0.28% 146
2017
Q4 		$267K Buy
3,727
+725
+24% +$55.1K 0.28% 150
2017
Q3 		$243K Sell
3,002
-12,676
-81% -$969K 0.3% 138
2017
Q2 		$1.11M Buy
+15,678
New +$1.04M 0.35% 101

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

StoneX Group's GILD Position: Q2 2026 in Review

StoneX Group reduced its Gilead Sciences (GILD) stake by 13% in Q2 2026, selling an estimated $44.4K and leaving 2,181 shares worth $276K. The position accounts for 0.01% of the portfolio, ranked #881.

StoneX Group first reported a position in GILD in Q2 2017 and has held it in 26 quarters since. The position peaked at $1.27M in Q3 2023. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • StoneX Group held 2,181 shares of Gilead Sciences worth $276K as of Q2 2026.
  • StoneX Group sold 337 Gilead Sciences shares in Q2 2026, an estimated $44.4K.
  • Gilead Sciences made up 0.01% of StoneX Group's portfolio in Q2 2026, its #881 holding.
  • StoneX Group first reported a position in Gilead Sciences in Q2 2017 and has held it in 26 quarters since.
  • StoneX Group's Gilead Sciences position peaked at $1.27M in Q3 2023.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.